headaches semaglutide Tirzepatide vs. Semaglutide: What's the Difference? Troubling Findings in Study of

As patients compare experiences, some report surprisingly meaningful symptom relief less bloating, fewer flares, even improved painwhile others notice no change or develop worsening gastrointestinal discomfort

Arun Sanyal, M.D., chief of the Division of Gastroenterology, Hepatology and Nutrition and director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health MASH affects around 15 million Americans, and currently there is only one FDA-approved treatment available, increasing the urgency for effective therapeutic options

From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown

Slattery et al., 2014)

doi: 10.1016/j.heliyon.2023.e15452

Pharma is pivoting toward preventive medicine as GLP-1 receptor agonists (drugs like Ozempic) show promise not just for obesity and diabetes but potentially for slowing aging itself